NRx Pharmaceuticals (NRXP) News Today $1.26 +0.03 (+2.44%) (As of 11/22/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period NRX Pharmaceuticals Strengthens Leadership with New CFO AppointmentNovember 20 at 9:14 PM | markets.businessinsider.comNRx Pharmaceuticals Names Michael Abrams CFONovember 20 at 12:52 AM | markets.businessinsider.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2024 Earnings Call TranscriptNovember 20 at 12:52 AM | msn.comNRx Pharmaceuticals, Inc.: NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as Chief Financial OfficerNovember 19, 2024 | finanznachrichten.deNRX Pharmaceuticals Inc (NRXP) Q3 2024 Earnings Call Highlights: Significant Reduction in ...November 19, 2024 | uk.finance.yahoo.comNRx Pharmaceuticals names Michael Abrams as CFONovember 19, 2024 | markets.businessinsider.comNRx Pharmaceuticals Reports Progress in Drug DevelopmentNovember 19, 2024 | markets.businessinsider.comNRx Pharmaceuticals, Inc. (NRXP) Q3 2024 Earnings Call TranscriptNovember 18, 2024 | seekingalpha.comNRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as Chief Financial OfficerNovember 18, 2024 | prnewswire.comNRX Pharmaceuticals Advances in Mental Health SectorNovember 15, 2024 | markets.businessinsider.comNRx Pharmaceuticals delays Q3 results call to November 18November 15, 2024 | uk.investing.comNRx Pharmaceuticals files to sell 3.3M shares of common stock for holdersNovember 15, 2024 | markets.businessinsider.comNRx Pharmaceuticals (NASDAQ:NRXP) Reports Third Quarter and Year to Date 2024 Financial Results and Provides Business UpdateNovember 14, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Conference Call to Discuss Third Quarter and Year to Date 2024 Financial Results to November 18, 2024November 13, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter and Year to Date 2024 Financial Results on November 14, 2024November 7, 2024 | prnewswire.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry ClinicsOctober 30, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024October 23, 2024 | globenewswire.comNRx Pharmaceuticals initiated with a Buy at EF HuttonOctober 22, 2024 | markets.businessinsider.comNRX Pharmaceuticals (NASDAQ:NRXP) Stock, Insider Trading ActivityOctober 16, 2024 | benzinga.comNRx Pharmaceuticals Leadership Shift and Strategic Governance DecisionsOctober 13, 2024 | finance.yahoo.comNRx Pharmaceuticals Advances Towards FDA Approval with Key Stability Milestone for NRX-100October 7, 2024 | msn.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric ClinicOctober 3, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine)September 30, 2024 | prnewswire.comNRx Pharmaceuticals’ Innovative Treatments for Depression Gain SpotlightSeptember 16, 2024 | msn.comNRX Pharmaceuticals (NASDAQ:NRXP) Stock Quotes, Forecast and News SummarySeptember 11, 2024 | benzinga.comNRX Pharmaceuticals (NASDAQ:NRXP) Stock, Short Interest ReportSeptember 11, 2024 | benzinga.comNRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.comSeptember 11, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. (Nasdaq:NRXP) and HOPE Therapeutics, Inc. Announce Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024September 3, 2024 | prnewswire.comNRXP Dec 2024 2.000 putAugust 31, 2024 | ca.finance.yahoo.comHOPE Therapeutics Announces $30 Mln Term Sheet From Lender - Quick FactsAugust 26, 2024 | markets.businessinsider.comHOPE Therapeutics Secures Financing For Ketamine Clinic ExpansionAugust 26, 2024 | msn.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry ClinicsAugust 26, 2024 | prnewswire.comNRx Pharmaceuticals Secures $16 Million in Convertible Debt FinancingAugust 19, 2024 | msn.comEarnings call: NRx Pharmaceuticals outlines key business advancementsAugust 18, 2024 | uk.investing.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q2 2024 Earnings Call TranscriptAugust 16, 2024 | msn.comNRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business UpdateAugust 14, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Second Quarter and Year to Date 2024 Financial Results on August 14, 2024August 13, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Up to $16 Million Senior Secured Debt Financing from Anson FundsAugust 13, 2024 | prnewswire.comNRx Pharmaceuticals Wins Arbitration to Proceed with HOPE Therapeutics SpinoffAugust 6, 2024 | msn.comNRx Pharmaceuticals cleared for HOPE Therapeutics spinoffJuly 31, 2024 | investing.comNRx Pharmaceuticals, Inc.: HOPE Therapeutics, Inc. and NRx Pharmaceuticals (Nasdaq:NRXP) Announce Arbitration Order Enabling HOPE Therapeutics SpinoffJuly 30, 2024 | finanznachrichten.deNRx Pharma, HOPE Therapeutics Align With FDA On Pediatric Study Plan For NRX-100July 30, 2024 | markets.businessinsider.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Alignment with FDA on Pediatric Study Plan for NRX-100 (ketamine)July 29, 2024 | prnewswire.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals (Nasdaq:NRXP) Announce Arbitration Order Enabling HOPE Therapeutics SpinoffJuly 29, 2024 | prnewswire.comNRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update LetterJuly 1, 2024 | prnewswire.comNRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for FilingJune 28, 2024 | prnewswire.comNRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024June 20, 2024 | prnewswire.comNRx Pharmaceuticals (NASDAQ:NRXP) Appoints Neuroscience, Information Technology and Medical Technology Veteran to its Board of DirectorsJune 18, 2024 | prnewswire.comNRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update LetterJune 10, 2024 | prnewswire.comNRx Pharmaceuticals (Nasdaq:NRXP) Presents Landmark Trial of NRX-101 in Suicidal Bipolar Depression At the American Society of Clinical Psychopharmacology Annual Meeting: NRX-101 is the First Oral Antidepressant Demonstrated to Reduce Suicidality in Bipolar DepressionMay 28, 2024 | prnewswire.com Get NRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Buffett Dumps $982 Million in BofA Stock—What Does He Know? (Ad)Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention. Get your FREE, no-obligation Wealth Protection Guide now NRXP Media Mentions By Week NRXP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NRXP News Sentiment▼0.320.49▲Average Medical News Sentiment NRXP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NRXP Articles This Week▼92▲NRXP Articles Average Week Get NRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Momentus News CervoMed News OptiNose News Entera Bio News Mural Oncology News Aadi Bioscience News Aileron Therapeutics News Theratechnologies News Kezar Life Sciences News Unicycive Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NRXP) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
